USP21 is involved in the development of chronic hepatitis B by modulating the immune microenvironment

USP21通过调节免疫微环境参与慢性乙型肝炎的发展。

阅读:1

Abstract

Hepatitis B virus (HBV) infection is a global public health challenge that alters the immune microenvironment of the liver and drives disease progression by triggering chronic inflammation that leads to hepatic cell death through multiple programmed cell death (PCD) modalities. Due to the persistence of covalently closed circular DNA in hepatocytes, there is a lack of curative drugs that can completely eradicate HBV. Therefore, revealing how HBV infection leads to changes in the hepatic immune microenvironment, as well as searching for specific molecular targets, is crucial for controlling the onset and progression of chronic hepatitis B (CHB). In this study, we used the single sample gene set enrichment analysis and CIBERSORT algorithms to assess immune cell infiltration in the livers of CHB patients. With three advanced machine learning algorithms, random forest, least absolute shrinkage and selection operator, and selected support vector machine recursive feature elimination, we identified the PCD signature genes associated with CHB from the candidate genes. We further validated that ubiquitin-specific peptidase 21 could differentiate CHB patients with different natural courses by receiver operating characteristic analysis. These findings enhance our understanding of the mechanisms of HBV infection.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。